G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B3GALT1 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B4GALNT4 | UDP-GalNAc |
|
R |
|
R | |
| B4GALNT3 | UDP-GalNAc |
|
R |
|
R | |
| B3GALNT2 | UDP-GalNAc |
|
R |
|
R | |
| B4GALT1 | UDP-Glc |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Gallus gallus |
| Antimicrobial peptides | Homo sapiens |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Xenopus tropicalis |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 35562392 | Shrimp thrombospondin (TSP): presence of O-β1,4 N-acetylglucosamine polymers and its function in TSP chain association in egg extracellular matrix | Magerd S | 2022 May 13 |
|
| 35544562 | A bioactive phlebovirus-like envelope protein in a hookworm endogenous virus | Merchant M | 2022 May 13 |
|
| 35551457 | Molecular insights into biogenesis of glycosylphosphatidylinositol anchor proteins | Xu Y | 2022 May 12 |
|
| 35549549 | Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody | Torres JL | 2022 May 12 |
|
| 35507661 | Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain | Gray MD | 2022 May 06 |
|
| 35507649 | Structural mapping of antibody landscapes to human betacoronavirus spike proteins | Bangaru S | 2022 May 06 |
|
| 35513511 | Cell-type-specific labeling and profiling of glycans in living mice | Fan X | 2022 May 05 |
|
| 35513753 | The interaction of O-GlcNAc-modified NLRX1 and IKK-α modulates IL-1β expression in M1 macrophages | Chen L | 2022 May 05 |
|
| 35219398 | Human CEACAM1 N-domain dimerization is independent from glycan modifications | Belcher Dufrisne M | 2022 May 05 |
|
| 35504898 | Dynamic O-GlcNAcylation coordinates ferritinophagy and mitophagy to activate ferroptosis | Yu F | 2022 May 03 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025